XML 33 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaborative Arrangements and Licensing Agreements, Biogen Idec (ISIS-DMPK) (Details) (Biogen Idec [Member], Agreement entered into in June 2012 [Member], ISIS-DMPK [Member], USD $)
1 Months Ended
Jun. 30, 2014
Jun. 30, 2012
Sep. 30, 2014
Collaborative Arrangement and Licensing Agreement [Abstract]      
Upfront fee recorded as deferred revenue   $ 12,000,000  
Milestone payment earned 14,000,000    
Next prospective milestone     35,000,000
License fee and substantive milestones [Member]
     
Collaborative Arrangement and Licensing Agreement [Abstract]      
Maximum amount of payment receivable     259,000,000
Cumulative milestone payments earned under collaborative arrangement at period end     24,000,000
Development milestones [Member]
     
Collaborative Arrangement and Licensing Agreement [Abstract]      
Maximum amount of payment receivable     35,000,000
Regulatory milestones [Member]
     
Collaborative Arrangement and Licensing Agreement [Abstract]      
Maximum amount of payment receivable     $ 130,000,000